• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于病毒样颗粒的策略来诱导针对 gp41 的α-螺旋区的 HIV 保护性抗体。

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.

机构信息

Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Via Stamira D'Ancona 20, 20127 Milan, Italy.

出版信息

Virology. 2012;431(1-2):1-11. doi: 10.1016/j.virol.2012.05.005. Epub 2012 Jun 2.

DOI:10.1016/j.virol.2012.05.005
PMID:22658900
Abstract

Natural antibodies to gp41 inhibit HIV-1 replication through the recognition of two different regions, corresponding to the leucine zipper motif in the HR1 alpha-helix and to another motif within HR2 region, hosting 2F5 and 4E10 epitope. This study aimed at reproducing such protective responses through VLP vaccination. Six regions covering the alpha-helical regions of gp41 were conjugated to the surface of AP205 phage-based VLPs. Once administered in mice via systemic or mucosal route, these immunogens elicited high titers of gp41-specific IgG. Immunogenicity and HIV infectivity reduction were obtained either with HR2 regions or with peptides where aminoacid strings were added to either the C-terminus or N-terminus of core epitope in HR1 region. Antibody-dependent cell cytotoxicity (ADCC) activity was induced by one of the HR2 epitopes only. These results may have relevant implications for the development of new vaccinal approaches against HIV infection.

摘要

天然针对 gp41 的抗体通过识别两个不同的区域来抑制 HIV-1 的复制,这两个区域分别对应 HR1 螺旋的亮氨酸拉链基序和 HR2 区域内的另一个基序,该基序包含 2F5 和 4E10 表位。本研究旨在通过 VLP 疫苗接种来重现这种保护性反应。将六个覆盖 gp41 的 α-螺旋区域的区域与基于 AP205 噬菌体的 VLPs 表面缀合。通过全身或粘膜途径在小鼠中给药后,这些免疫原引发了针对 gp41 的高滴度 IgG。通过 HR2 区域或通过在 HR1 区域的核心表位的 C 末端或 N 末端添加氨基酸序列,获得了免疫原性和 HIV 感染性降低。仅 HR2 表位之一可诱导抗体依赖性细胞毒性 (ADCC) 活性。这些结果可能对开发针对 HIV 感染的新疫苗接种方法具有重要意义。

相似文献

1
Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.基于病毒样颗粒的策略来诱导针对 gp41 的α-螺旋区的 HIV 保护性抗体。
Virology. 2012;431(1-2):1-11. doi: 10.1016/j.virol.2012.05.005. Epub 2012 Jun 2.
2
Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.牛乳头瘤病毒样颗粒展示了 HIV-1 gp41 膜近端外部区域的保守表位,诱导了黏膜和系统抗体。
Vaccine. 2013 Nov 4;31(46):5422-9. doi: 10.1016/j.vaccine.2013.09.003. Epub 2013 Sep 19.
3
Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.通过免疫接种融合后 HR1/HR2 复合物产生 HIV-1 强效且广谱的中和抗体。
AIDS. 2013 Mar 13;27(5):717-30. doi: 10.1097/QAD.0b013e32835cfca5.
4
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.病毒样颗粒表面嵌入膜的HIV-1包膜引发的免疫反应比可溶性包膜更广泛。
Virology. 2007 Feb 20;358(2):334-46. doi: 10.1016/j.virol.2006.08.032. Epub 2006 Sep 28.
5
Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.通过口服牛乳头瘤病毒-1型人类免疫缺陷病毒(HIV-1)gp41嵌合病毒样颗粒诱导针对HIV-1的黏膜和全身中和抗体。
J Virol. 2004 Aug;78(15):8342-8. doi: 10.1128/JVI.78.15.8342-8348.2004.
6
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.具有转运能力的流感血凝素/艾滋病毒包膜嵌合蛋白的抗原特性。
Virology. 2006 Aug 15;352(1):74-85. doi: 10.1016/j.virol.2006.04.012. Epub 2006 May 24.
7
Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.生成表达不同 HIV-1 糖蛋白的 HIV-1 病毒样颗粒。
Vaccine. 2011 Jul 12;29(31):4903-12. doi: 10.1016/j.vaccine.2011.05.005. Epub 2011 May 17.
8
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.采用不同缀合物的新型 HIV-1 gp41 表位的 Prime boost 疫苗接种方法可诱导小鼠产生中和抗体,该表位包含膜近端外区。
Vaccine. 2012 Mar 2;30(11):1911-6. doi: 10.1016/j.vaccine.2012.01.026. Epub 2012 Jan 23.
9
Antibodies purified from sera of HIV-1-infected patients by affinity on the heptad repeat region 1/heptad repeat region 2 complex of gp41 neutralize HIV-1 primary isolates.通过与gp41的七肽重复区域1/七肽重复区域2复合物亲和作用从HIV-1感染患者血清中纯化得到的抗体可中和HIV-1原代分离株。
AIDS. 2008 Oct 18;22(16):2075-85. doi: 10.1097/QAD.0b013e3283101260.
10
Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen.多个串联的保守 gp41 表位被整合到 gag 病毒样颗粒中,在优化的异源载体传递方案中诱导系统和黏膜抗体。
Vaccine. 2010 Oct 8;28(43):7070-80. doi: 10.1016/j.vaccine.2010.08.009. Epub 2010 Aug 17.

引用本文的文献

1
Colloidal Crystallization of Virus-Like Particles with Polycations.病毒样颗粒与聚阳离子的胶体结晶
Small. 2025 Aug;21(34):e2503579. doi: 10.1002/smll.202503579. Epub 2025 Jul 2.
2
Structural mechanisms of Tad pilus assembly and its interaction with an RNA virus.Tad菌毛组装的结构机制及其与一种RNA病毒的相互作用。
Sci Adv. 2024 May 3;10(18):eadl4450. doi: 10.1126/sciadv.adl4450.
3
How promising are HIV-1-based virus-like particles for medical applications.基于 HIV-1 的病毒样颗粒在医学应用中前景如何。
Front Cell Infect Microbiol. 2022 Oct 7;12:997875. doi: 10.3389/fcimb.2022.997875. eCollection 2022.
4
Development of a Platform for Noncovalent Coupling of Full Antigens to Tobacco Etch Virus-Like Particles by Means of Coiled-Coil Oligomerization Motifs.利用卷曲螺旋寡聚化模体开发将全抗原非共价偶联到烟草蚀纹病毒样颗粒的平台。
Molecules. 2021 Jul 23;26(15):4436. doi: 10.3390/molecules26154436.
5
Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines.基于病毒样颗粒的 HIV-1 疫苗的设计理念。
Front Immunol. 2020 Sep 30;11:573157. doi: 10.3389/fimmu.2020.573157. eCollection 2020.
6
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics".基于病毒样颗粒疫苗的 3D 策略:“设计、传递和动力学”。
Immunol Rev. 2020 Jul;296(1):155-168. doi: 10.1111/imr.12863. Epub 2020 May 30.
7
A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.基于 HBsAg VLP 的通用即插即用疫苗载体,最大限度地提高有效抗体应答。
Front Immunol. 2019 Dec 12;10:2931. doi: 10.3389/fimmu.2019.02931. eCollection 2019.
8
Synthetic biology for bioengineering virus-like particle vaccines.合成生物学在工程病毒样颗粒疫苗中的应用。
Biotechnol Bioeng. 2019 Apr;116(4):919-935. doi: 10.1002/bit.26890. Epub 2018 Dec 31.
9
Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target.膜近端外部区域的免疫学见解:人类免疫缺陷病毒1型主要疫苗靶点
Front Immunol. 2017 Sep 19;8:1154. doi: 10.3389/fimmu.2017.01154. eCollection 2017.
10
Platform technologies for modern vaccine manufacturing.现代疫苗制造的平台技术。
Vaccine. 2017 Aug 16;35(35 Pt A):4480-4485. doi: 10.1016/j.vaccine.2017.02.069. Epub 2017 Mar 25.